Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion.

Aim: To study the effect of superselective ophthalmic artery fibrinolysis as a treatment for central retinal vein occlusion (CRVO).

Methods: Retrospective, university based single centre study. The charts of 26 eyes of 26 patients treated were reviewed.